JP2021113190A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021113190A5 JP2021113190A5 JP2021012521A JP2021012521A JP2021113190A5 JP 2021113190 A5 JP2021113190 A5 JP 2021113190A5 JP 2021012521 A JP2021012521 A JP 2021012521A JP 2021012521 A JP2021012521 A JP 2021012521A JP 2021113190 A5 JP2021113190 A5 JP 2021113190A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- antibody
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862657172P | 2018-04-13 | 2018-04-13 | |
| US62/657,172 | 2018-04-13 | ||
| EP18208332.9 | 2018-11-26 | ||
| EP18208332 | 2018-11-26 | ||
| JP2019562323A JP6861301B2 (ja) | 2018-04-13 | 2019-04-11 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562323A Division JP6861301B2 (ja) | 2018-04-13 | 2019-04-11 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021113190A JP2021113190A (ja) | 2021-08-05 |
| JP2021113190A5 true JP2021113190A5 (https=) | 2022-04-15 |
Family
ID=66542473
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562323A Expired - Fee Related JP6861301B2 (ja) | 2018-04-13 | 2019-04-11 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
| JP2021012521A Pending JP2021113190A (ja) | 2018-04-13 | 2021-01-28 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562323A Expired - Fee Related JP6861301B2 (ja) | 2018-04-13 | 2019-04-11 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11780927B2 (https=) |
| EP (1) | EP3774913A1 (https=) |
| JP (2) | JP6861301B2 (https=) |
| KR (1) | KR20200143718A (https=) |
| CN (1) | CN111971307A (https=) |
| AU (1) | AU2019252858A1 (https=) |
| BR (1) | BR112020020277A2 (https=) |
| CA (1) | CA3094600A1 (https=) |
| CL (1) | CL2020002622A1 (https=) |
| IL (1) | IL277828A (https=) |
| MX (1) | MX2020010722A (https=) |
| TW (1) | TW201943731A (https=) |
| WO (1) | WO2019198019A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020225736A1 (en) * | 2019-05-08 | 2020-11-12 | Novartis Ag | Anti-cd40 antibodies for use in treatment of t1dm and insulitis |
| CN116234909A (zh) * | 2020-08-21 | 2023-06-06 | 上海药明生物技术有限公司 | Cd40激动剂抗体和使用方法 |
| WO2022090194A1 (en) * | 2020-10-26 | 2022-05-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for assessing the area under the curve of an immunosuppressant and associated method and systems |
| EP4402174A1 (en) * | 2021-09-17 | 2024-07-24 | Novartis AG | Methods for prevention of graft rejection in xenotransplantation |
| WO2025117849A1 (en) * | 2023-11-28 | 2025-06-05 | Eledon Pharmaceuticals, Inc. | Methods and compositions for prevention of transplant rejection |
| WO2025184603A2 (en) | 2024-03-01 | 2025-09-04 | Regeneron Pharmaceuticals, Inc. | The use of cd40 inhibitors for inhibiting an immune response and enabling immunogen administration and re-administration |
| WO2025184567A1 (en) | 2024-03-01 | 2025-09-04 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host anti-aav antibody response |
| WO2025235683A1 (en) * | 2024-05-07 | 2025-11-13 | Eledon Pharmaceuticals, Inc. | Methods and compositions for prevention of transplant rejection |
| WO2025235670A1 (en) | 2024-05-07 | 2025-11-13 | Eledon Pharmaceuticals, Inc. | Use of anti-cd40 ligand antibodies for immunosuppression in islet cell transplantation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| GB8809129D0 (en) | 1988-04-18 | 1988-05-18 | Celltech Ltd | Recombinant dna methods vectors and host cells |
| BRPI0417266B8 (pt) | 2003-12-25 | 2021-05-25 | Kyowa Hakko Kirin Co Ltd | anticorpo monoclonal, seu uso e composição farmacêutica |
| CN101014386A (zh) * | 2004-04-27 | 2007-08-08 | 诺华疫苗和诊断公司 | 拮抗性抗－cd40单克隆抗体及其使用方法 |
| EP1854810A1 (en) | 2006-05-09 | 2007-11-14 | PanGenetics B.V. | Deimmunized antagonistic anti-human CD40 monoclonal antibody from the ch5D12 antibody |
| BR112012024713B1 (pt) | 2010-03-31 | 2021-02-17 | Boehringer Ingelheim International Gmbh | anticorpo humanizado, seus usos e composição farmacêutica que o compreende |
| AR083847A1 (es) * | 2010-11-15 | 2013-03-27 | Novartis Ag | Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40 |
| US11780977B2 (en) * | 2020-08-10 | 2023-10-10 | Dover Chemical Corporation | Polymer compositions having an improved printable surface and related methods |
-
2019
- 2019-04-11 JP JP2019562323A patent/JP6861301B2/ja not_active Expired - Fee Related
- 2019-04-11 BR BR112020020277-0A patent/BR112020020277A2/pt not_active Application Discontinuation
- 2019-04-11 KR KR1020207032429A patent/KR20200143718A/ko not_active Withdrawn
- 2019-04-11 WO PCT/IB2019/052976 patent/WO2019198019A1/en not_active Ceased
- 2019-04-11 TW TW108112758A patent/TW201943731A/zh unknown
- 2019-04-11 MX MX2020010722A patent/MX2020010722A/es unknown
- 2019-04-11 EP EP19724250.6A patent/EP3774913A1/en not_active Withdrawn
- 2019-04-11 CA CA3094600A patent/CA3094600A1/en active Pending
- 2019-04-11 AU AU2019252858A patent/AU2019252858A1/en not_active Abandoned
- 2019-04-11 US US17/046,684 patent/US11780927B2/en active Active
- 2019-04-11 CN CN201980024663.8A patent/CN111971307A/zh active Pending
-
2020
- 2020-10-06 IL IL277828A patent/IL277828A/en unknown
- 2020-10-09 CL CL2020002622A patent/CL2020002622A1/es unknown
-
2021
- 2021-01-28 JP JP2021012521A patent/JP2021113190A/ja active Pending
-
2023
- 2023-09-01 US US18/459,922 patent/US20240287198A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021113190A5 (https=) | ||
| Gorantla et al. | Immunosuppressive agents in transplantation: Mechanisms of action and current anti‐rejection strategies | |
| Lebranchu et al. | Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy | |
| JP5722524B2 (ja) | 補体活性を抑制することによる同種移植片の生存の延長 | |
| US20110177027A1 (en) | COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha | |
| US20170267751A1 (en) | Prolongation of survival of an allograft by inhibiting complement activity | |
| EP0932415A1 (en) | Method of preventing acute rejection following solid organ transplantation | |
| US6214342B1 (en) | Method for increasing mean survival times of transplants with LFA-1-specific antibodies | |
| KR20030034177A (ko) | 허혈성 질환 치료제 | |
| CN105251004A (zh) | 在诊断和治疗类风湿性关节炎中使用的包含抗-cd6单克隆抗体的药物组合物 | |
| JPS6256440A (ja) | 不要細胞の分解あるいは阻止物質からなる治療剤 | |
| US8435520B2 (en) | Combinations of immunosuppressive agents for the treatment or prevention of graft rejections | |
| Niemeyer et al. | Long-term safety, tolerability and efficacy of daclizumab (Zenapax®) in a two-dose regimen in liver transplant recipients | |
| PT1737490E (pt) | Processos de tratamento da aterosclerose | |
| KR20080089645A (ko) | 암의 적출 장기 관류 병용 요법 | |
| RU2020137096A (ru) | Антитела к cd40 для применения в предотвращении отторжения трансплантата | |
| JP3168005B2 (ja) | 病気の処置 | |
| Tung et al. | Prolonged limb allograft survival with CD40 costimulation blockade, T‐cell depletion, and megadose donor bone‐marrow transfusion | |
| RU2021135507A (ru) | Антитела к cd40 для применения в лечении t1dm и инсулита | |
| CN118973600A (zh) | 用于脐带血移植后的血细胞恢复的药物组合物 | |
| KR20250120401A (ko) | 이식물 및 수혜자의 생존을 연장하기 위한 조성물 및 방법 | |
| Wills et al. | A Practical Approach to theUse of Intravenous Immunoglobulin in Neurological Disease | |
| RU2020117365A (ru) | Антитела к cd40 для применения в лечении синдрома шегрена | |
| HK40124218A (zh) | 延长移植物和受体存活期的组合物和方法 | |
| Walden | ORTHOCLONE OKT® 3 |